Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary molar root canal treatment with CTZ paste versus zinc oxide-eugenol
RBR-8xt8wxPhase 4Recruiting
- Sponsor
- Universidade Federal do Piauí
- Start
- Jun 2018
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of chloramphenicol + tetracycline + zinc oxide + eugenol and zinc oxide + eugenol in pulpal necrosis (2 arms), sponsored by Universidade Federal do Piauí. Primary endpoints: Clinical success and Radiographic success. Started Jun 2018; status: recruiting.
02
Drugs
chloramphenicol + tetracycline + zinc oxide + eugenolzinc oxide + eugenol
03
Conditions
pulpal necrosis
Beyond the preview
Go deeper on RBR-8xt8wx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8xt8wx.